Ayala Pharmaceuticals EV / EBITDA
Was ist das EV / EBITDA von Ayala Pharmaceuticals?
EV / EBITDA von Ayala Pharmaceuticals Inc. ist 2.04
Was ist die Definition von EV / EBITDA?
EV / EBITDA ist der Unternehmenswert geteilt durch das Einkommen vor Zinsen, Steuern, Abschreibungen und Amortisationen. Es ist ein Maß dafür, wie teuer eine Aktie ist und für Vergleiche zwischen Unternehmen häufiger gültig ist als das Preis-Gewinn-Verhältnis. Er misst den Preis (in Form des Unternehmenswerts), den ein Investor zu Gunsten des Cashflows des Unternehmens (in Form des EBITDA) bezahlt.
Price to earnings ratios are impacted by a company's choice of capital structure - companies which raise money via debt will have lower P/Es (and therefore look cheaper) than companies that raise an equivalent amount of money by issuing shares, even though the two companies might have equivalent enterprise values. A sample case is when a company with debt were to raise money by issuing shares of stock, and then used the money to pay off the debt, this company's P/E ratio would shoot up because of the increased number of shares - although nothing about the fundamental value of the business has changed. EV / EBITDA is unaffected by capital structure as enterprise value includes the value of debt, and EBITDA is available to all investors (debt and equity) as it excludes interest payments on that debt. It is ideal for analysts and potential investors looking to compare companies within the same industry.
EV / EBITDA von Unternehmen in Health Care Sektor auf NASDAQ im Vergleich zu Ayala Pharmaceuticals
Was macht Ayala Pharmaceuticals?
advaxis (nasdaq: adxs) is a late -stage biotechnology company developing multiple cancer immunotherapies based on its proprietary platform that redirects the immune system to kill cancer. the advaxis technology, using bioengineered live attenuated bacteria, listeria monocytogenes (lm), actively suppresses key components in the tumor microenvironment that contribute to the tumors growth and protection from immunologic attack.
Unternehmen mit ev / ebitda ähnlich Ayala Pharmaceuticals
- Eastern Platinum hat EV / EBITDA von 2.02
- Evadix Sa hat EV / EBITDA von 2.03
- Modern Living Investments hat EV / EBITDA von 2.03
- NOVATEK JSC hat EV / EBITDA von 2.03
- Epsilon hat EV / EBITDA von 2.03
- The Indian Card Clothing hat EV / EBITDA von 2.03
- Ayala Pharmaceuticals hat EV / EBITDA von 2.04
- Societe Francaise de Gestion et d'Investissement hat EV / EBITDA von 2.04
- TXCOM Societe Anonyme hat EV / EBITDA von 2.04
- ECI Technology hat EV / EBITDA von 2.04
- Eurobio Scientific Societe anonyme hat EV / EBITDA von 2.04
- Dsv A/S hat EV / EBITDA von 2.05
- Altamir SCA hat EV / EBITDA von 2.06